Sign in

CIK 0001829802

  • Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 12 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-25 Cambrian BioPharma Inc 10% owner Purchase +12,000 $15.79 $189K 4,763,794
2021-02-24 Peyer James Director Purchase +18,100 $16.84 $305K 4,750,894
2021-02-24 Peyer James Director Purchase +900 $18.42 $17K 4,751,794
2021-02-24 Cambrian BioPharma Inc 10% owner Purchase +18,100 $16.84 $305K 4,750,894
2021-02-24 Cambrian BioPharma Inc 10% owner Purchase +900 $18.42 $17K 4,751,794
2021-02-23 Peyer James Director Purchase +6,000 $17.04 $102K 4,718,494
2021-02-23 Peyer James Director Purchase +14,300 $18.10 $259K 4,732,794
2021-02-23 Cambrian BioPharma Inc 10% owner Purchase +6,000 $17.04 $102K 4,718,494
2021-02-23 Cambrian BioPharma Inc 10% owner Purchase +14,300 $18.10 $259K 4,732,794
2021-02-22 Cambrian BioPharma Inc 10% owner Purchase +9,802 $18.88 $185K 4,712,494
2021-02-22 Peyer James Director Purchase +9,802 $18.88 $185K 4,712,494
2021-02-19 Peyer James Director Purchase +11,786 $19.77 $233K 4,702,692
2021-02-19 Cambrian BioPharma Inc 10% owner Purchase +11,786 $19.77 $233K 4,702,692
2021-02-18 Peyer James Director Purchase +752 $19.75 $15K 4,690,905
2021-02-18 Cambrian BioPharma Inc 10% owner Purchase +752 $19.75 $15K 4,690,905
2021-02-18 Peyer James Director Purchase +753 $19.75 $15K 4,690,906
2021-02-18 Cambrian BioPharma Inc 10% owner Purchase +753 $19.75 $15K 4,690,906
2021-02-08 RICKS THOMAS G Director Conversion +301,769 301,769
2021-02-08 RICKS THOMAS G Director Conversion · Series AA Preferred Convertible Stock −11,447,156 0
2021-02-08 RICKS THOMAS G Director Conversion · Series BB Preferred Convertible Stock −3,037,849 0

Page 19 of 20 · 385 trades